ArticleVaccines2025

Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer.

Sara Huerta-Yepez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.